| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC | Chief Financial Officer and Chief Operating Officer | Common Stock | 308K | $2.41M | $7.81 | Feb 11, 2025 | Direct |
| OCULAR THERAPEUTIX, INC | Chief Financial Officer and Chief Operating Officer | Stock Option (Right to Buy) | 344K | Feb 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | Feb 11, 2025 | 2 | $0 | 4 | Feb 13, 2025 | Chief Financial Officer and Chief Operating Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Jan 31, 2025 | 2 | -$136K | 4 | Feb 4, 2025 | Chief Financial Officer and Chief Operating Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Aug 29, 2024 | 2 | $0 | 4 | Sep 3, 2024 | Chief Operating Officer and Chief Financial Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Feb 3, 2024 | 3 | $30.2K | 4 | Feb 6, 2024 | Chief Financial Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Jan 31, 2024 | 1 | -$31.8K | 4 | Feb 2, 2024 | Chief Financial Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Feb 6, 2023 | 1 | -$27.5K | 4 | Feb 8, 2023 | Chief Financial Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | Chief Financial Officer |
| OCUL | OCULAR THERAPEUTIX, INC | Feb 3, 2022 | 2 | $0 | 4 | Feb 7, 2022 | Chief Financial Officer |